US Stock MarketDetailed Quotes
BCTX BriaCell Therapeutics
- 0.960
- +0.118+13.96%
Trading Nov 29 12:48 ET
34.73MMarket Cap-3310P/E (TTM)
1.010High0.850Low1.45MVolume0.850Open0.842Pre Close1.36MTurnover4.58%Turnover RatioLossP/E (Static)36.18MShares5.97052wk High-14.54P/B30.38MFloat Cap0.46452wk Low--Dividend TTM31.65MShs Float12.470Historical High--Div YieldTTM19.00%Amplitude0.464Historical Low0.937Avg Price1Lot Size
BriaCell Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | (Q1)Oct 31, 2023 | (FY)Jul 31, 2023 | (Q4)Jul 31, 2023 | (Q3)Apr 30, 2023 | (Q2)Jan 31, 2023 | (Q1)Oct 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -95.94%862.09K | -95.94%862.09K | -96.68%935.69K | -81.36%6.24M | -63.56%13.65M | -48.22%21.25M | -48.22%21.25M | -36.74%28.17M | -30.18%33.5M | -32.51%37.45M |
| -Cash and cash equivalents | -95.94%862.09K | -95.94%862.09K | -96.68%935.69K | -81.36%6.24M | -63.56%13.65M | -48.22%21.25M | -48.22%21.25M | -36.74%28.17M | -30.18%33.5M | -32.51%37.45M |
| Receivables | 90.74%1.37M | 90.74%1.37M | 2.26%15.23K | 237.65%30.15K | -27.91%21.41K | 2,877.81%717.74K | 2,877.81%717.74K | 2.50%14.9K | -67.14%8.93K | 53.64%29.7K |
| -Accounts receivable | ---- | ---- | 2.26%15.23K | 237.65%30.15K | -27.91%21.41K | ---- | ---- | 2.50%14.9K | -67.14%8.93K | 53.64%29.7K |
| -Other receivables | 90.74%1.37M | 90.74%1.37M | ---- | ---- | ---- | --717.74K | --717.74K | ---- | ---- | ---- |
| Prepaid assets | -71.43%1.42M | -71.43%1.42M | 247.43%4.58M | 1,173.25%5.47M | 538.81%4.74M | 288.75%4.98M | 288.75%4.98M | -21.78%1.32M | 39.93%429.4K | 82.44%742.12K |
| Total current assets | -86.44%3.65M | -86.44%3.65M | -81.26%5.53M | -65.40%11.74M | -51.84%18.41M | -36.36%26.95M | -36.36%26.95M | -36.18%29.5M | -29.76%33.94M | -31.64%38.22M |
| Non current assets | ||||||||||
| Net PPE | --388.18K | --388.18K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| -Gross PPE | --456.8K | --456.8K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| -Accumulated depreciation | ---68.63K | ---68.63K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Goodwill and other intangible assets | -7.10%199.8K | -7.10%199.8K | -6.98%203.61K | -6.86%207.43K | -6.74%211.25K | -6.63%215.07K | -6.63%215.07K | -6.52%218.89K | -6.42%222.7K | -6.32%226.52K |
| -Other intangible assets | -7.10%199.8K | -7.10%199.8K | ---- | ---- | ---- | -6.63%215.07K | -6.63%215.07K | ---- | ---- | ---- |
| Investments and advances | 20,924,400.00%418.49K | 20,924,400.00%418.49K | 23,482,900.00%469.66K | 14,082,750.00%281.66K | 0.00%2 | 0.00%2 | 0.00%2 | 0.00%2 | 0.00%2 | 0.00%2 |
| Non current prepaid assets | --1.21M | --1.21M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Total non current assets | 931.48%2.22M | 931.48%2.22M | 207.59%673.27K | 119.61%489.09K | -6.74%211.25K | -6.63%215.07K | -6.63%215.07K | -6.52%218.89K | -6.42%222.71K | -6.32%226.52K |
| Total assets | -78.38%5.87M | -78.38%5.87M | -79.13%6.2M | -64.20%12.23M | -51.58%18.62M | -36.20%27.16M | -36.20%27.16M | -36.03%29.72M | -29.64%34.16M | -31.53%38.45M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | 538.12%7.17M | 538.12%7.17M | 545.30%6.42M | 537.21%3.71M | -45.20%433.92K | 142.56%1.12M | 142.56%1.12M | --995.25K | --582.45K | --791.75K |
| -accounts payable | 538.12%7.17M | 538.12%7.17M | 545.30%6.42M | 537.21%3.71M | -45.20%433.92K | 142.56%1.12M | 142.56%1.12M | --995.25K | --582.45K | --791.75K |
| Current accrued expenses | -57.15%290.38K | -57.15%290.38K | -13.53%335.36K | 142.00%212.87K | 236.03%612.59K | 41.84%677.72K | 41.84%677.72K | --387.84K | --87.96K | --182.3K |
| Current liabilities | 314.17%7.46M | 314.17%7.46M | 388.60%6.76M | 485.36%3.92M | 7.44%1.05M | 91.42%1.8M | 91.42%1.8M | 277.59%1.38M | 10.78%670.41K | 125.81%974.05K |
| Non current liabilities | ||||||||||
| Derivative product liabilities | -96.24%1.1M | -96.24%1.1M | -83.41%5.68M | -52.19%16.62M | -44.53%15.06M | -6.92%29.14M | -6.92%29.14M | 12,195.84%34.23M | 13,893.32%34.77M | 8,763.43%27.14M |
| Total non current liabilities | -96.24%1.1M | -96.24%1.1M | -83.41%5.68M | -52.19%16.62M | -44.53%15.06M | -6.92%29.14M | -6.92%29.14M | 12,195.84%34.23M | 13,893.32%34.77M | 8,046.13%27.14M |
| Total liabilities | -72.34%8.56M | -72.34%8.56M | -65.08%12.44M | -42.02%20.55M | -42.73%16.1M | -4.05%30.94M | -4.05%30.94M | 5,424.26%35.61M | 4,051.87%35.44M | 3,577.44%28.12M |
| Shareholders'equity | ||||||||||
| Share capital | 3.70%72.17M | 3.70%72.17M | 6.10%69.59M | 6.10%69.59M | 6.10%69.59M | 6.10%69.59M | 6.10%69.59M | 17.44%65.59M | 21.60%65.59M | 18.48%65.59M |
| -common stock | 3.70%72.17M | 3.70%72.17M | 6.10%69.59M | 6.10%69.59M | 6.10%69.59M | 6.10%69.59M | 6.10%69.59M | 17.44%65.59M | 21.60%65.59M | 18.48%65.59M |
| Retained earnings | -5.94%-85.44M | -5.94%-85.44M | -7.66%-84.23M | -17.19%-85.95M | -21.47%-74.65M | -33.64%-80.65M | -33.64%-80.65M | -183.63%-78.23M | -222.24%-73.34M | -238.78%-61.46M |
| Paid-in capital | ---- | ---- | ---- | ---- | 24.90%7.92M | ---- | ---- | --6.89M | --6.61M | --6.34M |
| Gains losses not affecting retained earnings | 0.00%-138.68K | 0.00%-138.68K | 0.00%-138.68K | 0.00%-138.68K | 0.00%-138.68K | 0.00%-138.68K | 0.00%-138.68K | 0.00%-138.68K | 0.00%-138.68K | 0.00%-138.68K |
| Other equity interest | 48.66%11.03M | 48.66%11.03M | --8.81M | --8.42M | ---- | --7.42M | --7.42M | ---- | ---- | ---- |
| Total stockholders'equity | 36.93%-2.38M | 36.93%-2.38M | -1.23%-5.97M | -530.42%-8.07M | -73.67%2.72M | -136.57%-3.78M | -136.57%-3.78M | -112.86%-5.89M | -102.68%-1.28M | -81.34%10.33M |
| Noncontrolling interests | ---302.52K | ---302.52K | ---267.94K | ---244.42K | ---205.11K | --0 | --0 | ---- | ---- | ---- |
| Total equity | 28.92%-2.68M | 28.92%-2.68M | -5.78%-6.23M | -549.50%-8.32M | -75.65%2.52M | -136.57%-3.78M | -136.57%-3.78M | -112.86%-5.89M | -102.68%-1.28M | -81.34%10.33M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
